Sectors
DWTX
Dogwood Therapeutics, Inc.
2.58
1 x 2.55
2 x 3.03
bid
ask
-
0.07
2.64%
02:02 PM
timesize
| Ytd | -37.98% | |
| 1y | -47.98% |
2.54
day range
2.74
1.28
52 week range
9.50
| Open | 2.61 | Prev Close | 2.65 | Low | 2.54 | High | 2.74 | Mkt Cap | 87.70M |
| Vol | 32.70K | Avg Vol | 78.18K | EPS | 1.89 | P/E | 1.37 | Forward P/E | -0.43 |
| Beta | 1.71 | Short Ratio | 0.42 | Inst. Own | 3.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.75 | 200-d Avg | 2.80 | 1yr Est | 13.83 |
| Income Statement | |||
| Operating Expenses | 14.06M | ||
| Research and Development Expense | 3.25M | ||
| Selling, General and Administrative Expense | 1.63M | ||
| Operating Income | -14.06M | ||
| Interest Expense | 66.35K | ||
| Income Tax Expense | -2.48M | ||
| Net Income | -11.53M | ||
| Net Income Common Stock | -11.53M | ||
| Net Income Common Stock (USD) | -11.53M | ||
| Consolidated Income | -11.53M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -13.94M | ||
| Earning Before Interest & Taxes (USD) | -13.94M | ||
| Weighted Average Shares | 34.13M | ||
| Weighted Average Shares Diluted | 34.13M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.61M | ||
| Cash and Equivalents (USD) | 9.61M | ||
| Current Assets | 11.03M | ||
| Property, Plant & Equipment Net | 142.57K | ||
| Total Assets | 80.50M | ||
| Total Debt | 69.56K | ||
| Current Liabilities | 2.83M | ||
| Debt Non-Current | 69.56K | ||
| Total Liabilities | 12.13M | ||
| Accumulated Retained Earnings (Deficit) | -124.59M | ||
| Accumulated Other Comprehensive Income | -2.99M | ||
| Shareholders Equity | 68.37M | ||
| Shareholders Equity (USD) | 68.37M | ||
| Assets Non-Current | 69.47M | ||
| Total Debt (USD) | 69.56K | ||
| Deferred Revenue | 37.56K | ||
| Goodwill and Intangible Assets | 69.31M | ||
| Liabilities Non-Current | 9.30M | ||
| Trade and Non-Trade Payables | 411.52K | ||
| Tax Liabilities | 9.20M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 16.69K | ||
| Net Cash Flow from Financing | 23.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.61M | ||
| Net Cash Flow from Operations | -3.61M | ||
| Effect of Exchange Rate Changes on Cash | -6.74K | ||
| Share Based Compensation | 543.20K | ||